Calamos Advisors’s Exelixis EXEL Stock Holding History

Calamos Advisors’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-298,900	Closed	-$7.76M	–	930
2024 Q4	$7.76M	Buy	+298,900	New	+$9.7M	0.03%	451

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Calamos Advisors's EXEL Position: Q1 2025 in Review

Calamos Advisors sold out of Exelixis (EXEL) in Q1 2025, closing a stake of 16,280 shares — an estimated $542K sold.

Calamos Advisors first reported a position in EXEL in Q1 2019 and held it in 4 quarters. The position peaked at $1.63M in Q4 2023. 557 funds tracked by Wall St. Rank hold EXEL as of Q1 2025.

Calamos Advisors reported no remaining Exelixis position as of Q1 2025 after selling out during the quarter.
Calamos Advisors sold 16,280 Exelixis shares in Q1 2025, an estimated $542K.
Calamos Advisors first reported a position in Exelixis in Q1 2019 and held it in 4 quarters.
Calamos Advisors's Exelixis position peaked at $1.63M in Q4 2023.
557 funds tracked by Wall St. Rank held Exelixis as of Q1 2025.

Based on Calamos Advisors's 13F filing for Q1 2025, filed 29 Apr 2025.